News

March 15, 2023 09:00 AM Eastern Daylight Time--VANCOUVER, British Columbia--Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field...

Extends HeartBeam’s Reach with FDA-cleared Halo+™ Atrial Fibrillation Detection System and Physician-prescribed Integrated Patient Care Platform

CARDIFF-BY-THE-SEA, Calif., March 15, 2023 /-- Today, Field Medical, Inc., an industry leader in focal pulsed field catheter ablation technology, announced that Mark Wisniewski, CFO of Enterra Medical Inc. and previous CFO of...

First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform

-Pivotal study expected to be completed by year-end 2023 and set the stage for commercialization of PerQseal® system for large hole vessel closure -Company announces €30 million strategic investment from Haemonetics as part of its previously...

Catheter Precision's LockeT Successfully Used in Series of Patients

Study will evaluate THERMOCOOL SMARTTOUCH™ SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation

Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services

PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation.

Pulsed field ablation shortens operating times and may reduce the chance of damage to surrounding tissues.